Session Information

Invited Symposium

[IS-TH-79] SOE Session: Retinoblastoma: Intra-Arterial or Intra-Vitreal Chemotherapy (or Perhaps Not at All)?
Go back
print
Day
Apr 03 (Thu)
Time
08:30 - 10:00
Room
Room 27 - Imperial Hotel 3F Mai
Topic
Oncology
Chair/Coordinator
Chair)Stefan Seregard、Chair)Akihiro Kaneko、Chair)Carol Shields
Description
Retinoblastoma is the most common primary intraocular malignancy in childhood. During the last few decades, management of this disease has dramatically changed and chemotherapy has emerged as first-line treatment. This is a major change of concept as chemotherapy once used to be the last line of resort. Chemotherapeutic drugs may now be delivered not only systemically, but also selectively into the ophthalmic artery or even directly into the vitreous cavity. The pros and cons of these routes and current indications will be discussed.

Duration 10min, Panel Discussion = 0min

IS-TH-79-1 / 

Oncology

Chemotherapy for Retinoblastoma: More Than One Way to Do the Trick

Stefan Seregard

Chemotherapy for Retinoblastoma: More Than One Way to Do the Trick

Duration 10min, Q&A 4min, Panel Discussion = 0min

IS-TH-79-2 / 

Oncology

Dangerous Floaters: Methods for Treatment of Vitreous Seeds from Retinoblastoma

Carol Shields

Dangerous Floaters: Methods for Treatment of Vitreous Seeds from Retinoblastoma

Duration 10min, Q&A 4min, Panel Discussion = 0min

IS-TH-79-3 / 

Oncology

Guidelines for Conservative Retinoblastoma Treatment in Curie Institute: Indications and Results of Intra-Arterial and Intra-Vitreal Melphalan

Laurence Desjardins

Guidelines for Conservative Retinoblastoma Treatment in Curie Institute: Indications and Results of Intra-Arterial and Intra-Vitreal Melphalan

Duration 10min, Q&A 4min, Panel Discussion = 0min

IS-TH-79-4 / 

Oncology

Intra-Arterial or Intra-Vitreal: The Importance of Pairing Drug and Technique

Matthew Wilson

Intra-Arterial or Intra-Vitreal: The Importance of Pairing Drug and Technique

Duration 10min, Q&A 4min, Panel Discussion = 0min

IS-TH-79-5 / 

Oncology

Intravitreal Chemotherapy for Vitreous Disease in Retinoblastoma: To Be or Taboo?

Francis Munier

Intravitreal Chemotherapy for Vitreous Disease in Retinoblastoma: To Be or Taboo?

Duration 10min, Q&A 4min, Panel Discussion = 0min

IS-TH-79-6 / 

Oncology

Misunderstandings Concerning Vitreous Injection of Melphalan for Eye-Preserving Therapy of Retinoblastoma

Akihiro Kaneko

Misunderstandings Concerning Vitreous Injection of Melphalan for Eye-Preserving Therapy of Retinoblastoma

Go back